Home Medizin Die Endocrine Society begrüßt das Veto des Gouverneurs von Ohio, DeWine, gegen das Anti-Transgender-Gesundheitsgesetz

Die Endocrine Society begrüßt das Veto des Gouverneurs von Ohio, DeWine, gegen das Anti-Transgender-Gesundheitsgesetz

von NFI Redaktion

The Endocrine Society, the world’s oldest and largest professional organization dedicated to the research and treatment of hormone-related disorders, welcomes Governor Mike Dewine’s veto of a bill in Ohio that would have banned gender-affirming care for minors. The bill he vetoed contradicts common medical practice and scientific understanding and would have bypassed medical decision making from families and their doctors to instead rely on government officials.

Over 2,000 scientific studies since 1975 have examined aspects of gender-affirming care, including more than 260 studies cited in the Clinical Practice Guideline of the Endocrine Society.

Major medical and scientific organizations, including the American Medical Association, the American Psychological Association, and the American Academy of Pediatrics, agree with the Endocrine Society on the importance of gender-affirming care.

In June, the Endocrine Society collaborated with other medical professional societies in the American Medical Association (AMA) House of Delegates to overwhelmingly pass a resolution protecting access to evidence-based, gender-affirming care for transgender and gender diverse individuals. This resolution committed the AMA to oppose any criminal or legal sanctions against patients seeking gender-affirming care, family members or caregivers supporting them in seeking medical care, and health facilities and physicians providing gender-affirming care.

Pediatric gender-affirming care is focused on a conservative approach. If young children feel their gender identity does not align with the sex assigned at birth, the first step is to support the child in exploringleir gender identity and provide psychological support when needed.

Medical interventions are reserved for older adolescents and adults. Treatment plans are tailored to the individual and designed to maximize the time teenagers and their families have to make decisions about their transitions.

As Governor Dewine pointed out, only a small number of children in Ohio would be affected by the proposed legislation, but it would have profound and potentially life-threatening consequences for those with gender dysphoria. Approximately 300,000 teenagers aged 13 to 17, or 1.4% of the population in the United States, identify as transgender. According to an analysis by Komodo Health Inc. for Reuters, an estimated 4,780 adolescents with a gender dysphoria diagnosis began taking puberty-blocking medications between 2017 and 2021.

Gender-affirming care can be life-saving for a population with high suicide rates. For example, a 2020 study analyzed survey data from 89 transgender adults who had access to puberty-blocking medications as adolescents and data from over 3,400 transgender adults who did not have access. The study found that those who received puberty-blocking hormone treatment were less likely to have lifetime suicidal ideation compared to those who desired but did not receive puberty-blocking treatment, even after accounting for demographic variables and the degree of family support. Approximately nine out of ten transgender adults who desired but did not receive puberty-blocking treatment reported lifetime suicidal ideation.

Medical decisions should be made by patients, their family members, and healthcare providers, not politicians.

Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.